JamesFrancisCummingsMD

Infectious Disease • Silver Spring, MD

Healthcare Associated Infections, International Health, Travel & Tropical

Assistant Professor, Medicine, Uniformed Services Hebert SOM

Join to view full profile

Dr. Cummings is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Cummings' full profile

Already have an account?

Office
11800 Tech Rd, Suite 220
Silver Spring, MD 20904
Phone+1 301-319-3268
Is this information wrong?

Education & Training

National Capital ConsortiumFellowship, Infectious Disease, 2002 - 2005
National Capital ConsortiumResidency, Internal Medicine, 1993 - 1996
Georgetown University School of MedicineClass of 1993

Certifications & Licensure

PA State Medical License 1997 - 2024
NC State Medical License 1998 - 2020
National Board of Physicians and Surgeons Infectious Disease
National Board of Physicians and Surgeons Internal Medicine

Clinical Trials

Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America Start of enrollment: 2006 Apr 01
Completed
Phase 1, Phase 2
Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America Start of enrollment: 2006 Apr 01
Completed
Phase 1, Phase 2
Study of the Safety and Immunogenicity of H1N1 Vaccine Start of enrollment: 2010 Sep 01
Completed
Phase 1

Publications & Presentations

PubMed

75 citations
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
Jason W. Bennett, Anjali Yadava, Donna Tosh, Jetsumon Sattabongkot, Jack Komisar, Lisa A. Ware, William F. McCarthy, Jessica Cowden, Jason A. Regules, Michele D. Sprin...> ;Plos Neglected Tropical Diseases. 2016 Feb 26
54 citations
Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-esca...
James F. Cummings, Melanie L. Guerrero, James E. Moon, Paige E. Waterman, Robin K. Nielsen, Stacie Jefferson, F. Liaini Gross, Kathy Hancock, Jacqueline M. Katz, Vidad...> ;Vaccine. 2014 Apr 17
107 citations
DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
Ilin Chuang, Martha Sedegah, Susan Cicatelli, Michele D. Spring, Mark E. Polhemus, Cindy Tamminga, Noelle B. Patterson, Melanie L. Guerrero, Jason W. Bennett, Shannon ...> ;Plos One. 2013 Feb 14
33 citations
Detection of qacA/B in clinical isolates of methicillin-resistant Staphylococcus aureus from a regional healthcare network in the eastern United States.
Patrick McGann, Yoon I. Kwak, Amy M. Summers, James F. Cummings, Paige E. Waterman, Emil Lesho> ;Infection Control and Hospital Epidemiology. 2011 Sep 20
3 citations
Plasmodium falciparum Infection during Suppressive Prophylaxis with Mefloquine Does Not Induce an Antibody Response to Merozoite Surface Protein-1(42)
James E. Moon, Gregory Deye, Lori Miller, Susan Fracisco, R. Scott Miller, Donna Tosh, James F. Cummings, Colin Ohrt, Alan J. Magill> ;The American Journal of Tropical Medicine and Hygiene. 2011 May 5
69 citations
The RTS,S vaccine candidate for malaria.
Jason A. Regules, James F. Cummings, Christian F. Ockenhouse> ;Expert Review of Vaccines. 2011 May 1
116 citations
A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protei...
Paul B. Keiser, S. Biggs-Cicatelli, E. E. Moran, Deborah H. Schmiel, Valerian B. Pinto, Robert Burden, Lori Miller, James E. Moon, Robert A. Bowden, James F. Cummings,...> ;Vaccine. 2011 Feb 4
67 citations
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect ag...
James F. Cummings, Michele D. Spring, Robert Schwenk, Christian F. Ockenhouse, Kent E. Kester, Mark E. Polhemus, Douglas S. Walsh, In-Kyu Yoon, Christine Prosperi, Lau...> ;Vaccine. 2010 Jul 12
85 citations
Expression of Genes Associated with Immunoproteasome Processing of Major Histocompatibility Complex Peptides Is Indicative of Protection with Adjuvanted RTS,S Malaria ...
Maryanne Vahey, Zhining Wang, Kent E. Kester, James F. Cummings, D. Gray Heppner, Martin E. Nau, Opokua Ofori-Anyinam, Joe Cohen, Thierry Coche, W. Ripley Ballou, Chri...> ;The Journal of Infectious Diseases. 2010 Feb 15
397 citations
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associat...
Kent E. Kester, James F. Cummings, Opokua Ofori-Anyinam, Christian F. Ockenhouse, Urszula Krzych, Philippe Moris, Robert Schwenk, Robin Nielsen, Zufan Debebe, Evgeny P...> ;The Journal of Infectious Diseases. 2009 Aug 1
99 citations
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
Mark E. Polhemus, Shon Remich, Bernhards Ogutu, John N. Waitumbi, Lucas Otieno, Stella Apollo, James F. Cummings, Kent E. Kester, Christian F. Ockenhouse, Stewart V An...> ;Plos One. 2009 Jul 31
162 citations
Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
Michele D. Spring, James F. Cummings, Christian F. Ockenhouse, Sheetij Dutta, Randall Reidler, Evelina Angov, Elke S. Bergmann-Leitner, V. Ann Stewart, Stacey Bittner,...> ;Plos One. 2009 Apr 23
107 citations
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute...
Kent E. Kester, James F. Cummings, Christian F. Ockenhouse, Robin Nielsen, B. Ted Hall, Daniel M. Gordon, Robert Schwenk, Urszula Krzych, Carolyn A. Holland, Gregory R...> ;Vaccine. 2008 Apr 24
1 citations
Persistence of Vaccinia at the Site of Smallpox Vaccination
James F. Cummings, Mark E. Polhemus, Clifton A. Hawkes, Mary M. Klote, George V. Ludwig, Glenn Wortmann> ;Clinical Infectious Diseases. 2008 Jan 1
17 citations
Visceral Leishmaniasis: Clinical Observations in 4 US Army Soldiers Deployed to Afghanistan or Iraq, 2002-2004
Otha Myles, Glenn Wortmann, James F. Cummings, R. Vincent Barthel, Sugat Patel, Nancy F. Crum-Cianflone, Nathan S. Negin, Peter J. Weina, Christian F. Ockenhouse, Dani...> ;Archives of Internal Medicine. 2007 Sep 24
77 citations
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults...
Mark E. Polhemus, Alan J. Magill, James F. Cummings, Kent E. Kester, Chris F. Ockenhouse, David E. Lanar, Sheetij Dutta, Arnoldo Barbosa, Lorraine Soisson, Carter L. D...> ;Vaccine. 2007 May 22
72 citations
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adul...
José A. Stoute, Joash Gombe, Mark R. Withers, Joram Siangla, Denise McKinney, Melanie Onyango, James F. Cummings, Jessica Milman, Kathryn Tucker, Lorraine Soisson, V. ...> ;Vaccine. 2007 Jan 2
26 citations
Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques.
V. Ann Stewart, Douglas S. Walsh, Shannon McGrath, Kent E. Kester, James F. Cummings, Gerald Voss, Martine Delchambre, Nathalie Garçon, Joe Cohen, D. Gray Heppner> ;Vaccine. 2006 Oct 30
76 citations
Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A ☆
V. Ann Stewart, Shannon McGrath, Douglas S. Walsh, Stacey Davis, Aaron S. Hess, Lisa A. Ware, Kent E. Kester, James F. Cummings, J. Robert Burge, Gerald Voss, Martine ...> ;Vaccine. 2006 Oct 30
105 citations
Common and Divergent Immune Response Signaling Pathways Discovered in Peripheral Blood Mononuclear Cell Gene Expression Patterns in Presymptomatic and Clinically Appar...
Christian F. Ockenhouse, Wan Chung Hu, Kent E. Kester, James F. Cummings, Stewart V Ann, D. Gray Heppner, Anne E. Jedlicka, Alan L. Scott, Nathan D. Wolfe, Maryanne Va...> ;Infection and Immunity. 2006 Oct 1
1 citations
Vaccinia DNA in blood after smallpox vaccination.
Mary M. Klote, Renata J.M. Engler, Bryan Martin, James F. Cummings, Glenn Wortmann, George V. Ludwig> ;JAMA. 2006 Sep 20
81 citations
Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.
Christian F. Ockenhouse, Evelina Angov, Kent E. Kester, Carter L. Diggs, Lorraine Soisson, James F. Cummings, Stewart V Ann, Dupeh R. Palmer, Babita Mahajan, Urszula K...> ;Vaccine. 2006 Apr 5
7 citations
CHARACTERIZATION OF A HUMAN REFERENCE STANDARD FOR ANTIBODY TO PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEIN 142
In-Kyu Yoon, Evelina Angov, David Larson, D. Gray Heppner, James F. Cummings, V. Ann Stewart> ;The American Journal of Tropical Medicine and Hygiene. 2005 Jun 1
146 citations
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
D. Gray Heppner, Kent E. Kester, Christian F. Ockenhouse, Nadia Tornieporth, Opokua Ofori, Jeffrey A. Lyon, V. Ann Stewart, Patrice M. Dubois, David E. Lanar, Urszula ...> ;Vaccine. 2005 Mar 18
24 citations
Lack of Vaccinia Viremia after Smallpox Vaccination
James F. Cummings, Mark E. Polhemus, Clifton A. Hawkes, Mary M. Klote, George V. Ludwig, Glenn Wortmann> ;Clinical Infectious Diseases. 2004 Feb 1
Join now to see all